Proapoptotic effects of novel thiazole derivative on human glioma cells. Issue 1 (January 2019)
- Record Type:
- Journal Article
- Title:
- Proapoptotic effects of novel thiazole derivative on human glioma cells. Issue 1 (January 2019)
- Main Title:
- Proapoptotic effects of novel thiazole derivative on human glioma cells
- Authors:
- Finiuk, Nataliya
Klyuchivska, Olha
Ivasechko, Iryna
Hreniukh, Volodymyr
Ostapiuk, Yuriy
Shalai, Yaryna
Panchuk, Rostyslav
Matiychuk, Vasyl
Obushak, Mykola
Stoika, Rostyslav
Babsky, Andriy - Abstract:
- Abstract : The aim of the present study was to investigate the antiproliferative and proapoptotic actions of N -(5-benzyl-1, 3-thiazol-2-yl)-3, 5-dimethyl-1-benzofuran-2-carboxamide derivative (compound 5) in glioma cells in comparison with the actions of temozolomide (TMZ) and doxorubicin (Dox), used as positive controls. The antiproliferative activity of the compound 5, TMZ, and Dox on human glioblastoma U251 and human glioblastoma multiform T98G cells was measured using the MTT test. Western blot analysis, fluorescent microscopy, agarose gel retardation assay, flow cytometric analysis, and the DNA comet assay under alkaline conditions were carried out to study the effect of compound 5 on U251 cells. This compound showed ~20 times higher cytotoxicity toward U251 and T98G cells compared with the effects of TMZ and approximately two times higher activity than that of the Dox. Compound 5 induced apoptosis in U251 cells by PARP1 and caspase 3 cleavage mechanisms, also inducing an increase in the level of Bax and Bim proapoptotic proteins and a decrease in the level of phosho-ERK1/2 kinase. The cytotoxicity of compound 5 was associated with an increase in the production of the hydrogen peroxide and the formation of DNA single-strand breaks. This compound 5 did not intercalate into a DNA molecule. Thus, the novel thiazole derivative (compound 5) proved to be a potential antiglioma drug that showed much higher cytotoxic action on human glioma cells compared with the effects ofAbstract : The aim of the present study was to investigate the antiproliferative and proapoptotic actions of N -(5-benzyl-1, 3-thiazol-2-yl)-3, 5-dimethyl-1-benzofuran-2-carboxamide derivative (compound 5) in glioma cells in comparison with the actions of temozolomide (TMZ) and doxorubicin (Dox), used as positive controls. The antiproliferative activity of the compound 5, TMZ, and Dox on human glioblastoma U251 and human glioblastoma multiform T98G cells was measured using the MTT test. Western blot analysis, fluorescent microscopy, agarose gel retardation assay, flow cytometric analysis, and the DNA comet assay under alkaline conditions were carried out to study the effect of compound 5 on U251 cells. This compound showed ~20 times higher cytotoxicity toward U251 and T98G cells compared with the effects of TMZ and approximately two times higher activity than that of the Dox. Compound 5 induced apoptosis in U251 cells by PARP1 and caspase 3 cleavage mechanisms, also inducing an increase in the level of Bax and Bim proapoptotic proteins and a decrease in the level of phosho-ERK1/2 kinase. The cytotoxicity of compound 5 was associated with an increase in the production of the hydrogen peroxide and the formation of DNA single-strand breaks. This compound 5 did not intercalate into a DNA molecule. Thus, the novel thiazole derivative (compound 5) proved to be a potential antiglioma drug that showed much higher cytotoxic action on human glioma cells compared with the effects of TMZ and Dox. Its cytotoxicity is associated with apoptosis induction, production of the reactive oxygen species, and formation of DNA single-strand breaks without significant DNA intercalation. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Anti-cancer drugs. Volume 30:Issue 1(2019)
- Journal:
- Anti-cancer drugs
- Issue:
- Volume 30:Issue 1(2019)
- Issue Display:
- Volume 30, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 30
- Issue:
- 1
- Issue Sort Value:
- 2019-0030-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-01
- Subjects:
- apoptosis -- DNA -- doxorubicin -- glioma -- proliferation -- reactive oxygen species -- temozolomide -- thiazole derivative
Antineoplastic agents -- Periodicals
Cancer -- Chemotherapy -- Periodicals
Antineoplastic Agents -- therapeutic use -- Periodicals
Drug Therapy -- Periodicals
616.994061 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00001813-000000000-00000 ↗
http://ovidsp.tx.ovid.com/spb/ovidweb.cgi ↗
http://www.anti-cancerdrugs.com/ ↗
http://journals.lww.com/pages/default.aspx ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1097/CAD.0000000000000686 ↗
- Languages:
- English
- ISSNs:
- 0959-4973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1547.287300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11214.xml